Salomon Manier, Noemi Puig, Xavier Leleu, Albert Oriol, Cyrille Hulin, Ramón García-Sanz, Jill Corre, Jesus San-Miguel, Thierry Facon, Hans Lee, Peter Forsberg, Kaustav Chatterjee, Anders Svensson, Chetasi Talati, Sunny He, Thomas Doerr, Emma Arriola, Myles Dillon, Jennifer Lin, Linh Nguyen, Fan Wang, María-Victoria Mateos. "A Phase 2/3, multicenter, randomized, open-label study evaluating the efficacy and safety of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in frailer transplant-ineligible patients with newly diagnosed multiple myeloma." Blood (2025). https://doi.org/10.1182/blood-2025-2288